IE42002L - Antigens-modified polypeptides - Google Patents
Antigens-modified polypeptidesInfo
- Publication number
- IE42002L IE42002L IE740967A IE96774A IE42002L IE 42002 L IE42002 L IE 42002L IE 740967 A IE740967 A IE 740967A IE 96774 A IE96774 A IE 96774A IE 42002 L IE42002 L IE 42002L
- Authority
- IE
- Ireland
- Prior art keywords
- human
- peptide
- antigens
- modified polypeptides
- active
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 2
- 102000004576 Placental Lactogen Human genes 0.000 abstract 2
- 108010003044 Placental Lactogen Proteins 0.000 abstract 2
- 239000000381 Placental Lactogen Substances 0.000 abstract 2
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 101000687438 Homo sapiens Prolactin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001592 luteinising effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The composition has an active immunising action against reproduction in humans and mammals. It contains as active component a biologically determinant peptide of one of the protein-reproducing hormones follicle-stimulating hormone (FSH), luteinising hormone (LH), human placental lactogen (HPL), human prolactin or human chorionic gonadotropin (HCG). The peptide is modified to an artificial antigen in an immunochemically known way.
[GB1473601A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35789273A | 1973-05-07 | 1973-05-07 | |
| US40682173A | 1973-10-16 | 1973-10-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE42002L true IE42002L (en) | 1974-11-07 |
| IE42002B1 IE42002B1 (en) | 1980-05-21 |
Family
ID=26999834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE967/74A IE42002B1 (en) | 1973-05-07 | 1974-05-07 | Antigen modification of polypeptides |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS623128B2 (en) |
| AT (1) | AT356263B (en) |
| AU (1) | AU524925B2 (en) |
| CA (1) | CA1057742A (en) |
| CH (1) | CH622426A5 (en) |
| DD (1) | DD113919A5 (en) |
| DE (1) | DE2421943A1 (en) |
| FR (1) | FR2228477B1 (en) |
| GB (1) | GB1473601A (en) |
| HK (1) | HK41280A (en) |
| IE (1) | IE42002B1 (en) |
| IL (1) | IL44779A (en) |
| MY (1) | MY8100128A (en) |
| NL (1) | NL7406098A (en) |
| NZ (1) | NZ174192A (en) |
| PL (1) | PL97318B1 (en) |
| SE (1) | SE7406096L (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
| CA1054937A (en) * | 1975-01-28 | 1979-05-22 | Gursaran P. Talwar | Antipregnancy vaccine |
| FR2319379A1 (en) * | 1975-07-29 | 1977-02-25 | All India Inst Medical Scie | Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium) |
| JPS55160725A (en) * | 1975-07-30 | 1980-12-13 | Paashiyado Taruwaa Gaasaran | Contraceptive vaccine and its manufacture |
| NZ182272A (en) * | 1975-10-14 | 1985-03-20 | Univ Ohio State | Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions |
| JPS5294416A (en) * | 1976-01-24 | 1977-08-09 | Paashiyado Taruwaa Gaasaran | Vaccine for contraception and use of same |
| JPS5633907Y2 (en) * | 1976-09-16 | 1981-08-11 | ||
| US4096237A (en) * | 1977-03-14 | 1978-06-20 | Hoffmann-La Roche Inc. | Immunoassay for β-endorphin |
| US4234561A (en) * | 1978-02-06 | 1980-11-18 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4310455A (en) * | 1979-04-17 | 1982-01-12 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| CA1239346A (en) * | 1985-06-04 | 1988-07-19 | Gursaran P. Talwar | Birth control vaccine |
| FR2832066A1 (en) * | 2001-11-14 | 2003-05-16 | Agronomique Inst Nat Rech | CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA903671A (en) * | 1972-06-27 | J. Lewis Andrew | Soluble cancer antigens coupled to foreign proteins | |
| DE1467782A1 (en) * | 1963-07-17 | 1968-12-12 | Behringwerke Ag | Process for the production of artificial antigens |
| US3317400A (en) * | 1964-11-23 | 1967-05-02 | Upjohn Co | Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts |
| GB1393965A (en) * | 1971-05-05 | 1975-05-14 | Ortho Pharma Corp | Vaccine and method for inducing infertility in a male animal |
-
1974
- 1974-05-03 CH CH604874A patent/CH622426A5/en not_active IP Right Cessation
- 1974-05-06 CA CA199,003A patent/CA1057742A/en not_active Expired
- 1974-05-07 FR FR7415780A patent/FR2228477B1/fr not_active Expired
- 1974-05-07 AU AU68695/74A patent/AU524925B2/en not_active Expired
- 1974-05-07 GB GB2001874A patent/GB1473601A/en not_active Expired
- 1974-05-07 IE IE967/74A patent/IE42002B1/en unknown
- 1974-05-07 AT AT377074A patent/AT356263B/en not_active IP Right Cessation
- 1974-05-07 NL NL7406098A patent/NL7406098A/xx not_active Application Discontinuation
- 1974-05-07 JP JP49051079A patent/JPS623128B2/ja not_active Expired
- 1974-05-07 PL PL1974170881A patent/PL97318B1/en unknown
- 1974-05-07 SE SE7406096A patent/SE7406096L/en unknown
- 1974-05-07 NZ NZ174192A patent/NZ174192A/en unknown
- 1974-05-07 DE DE2421943A patent/DE2421943A1/en active Granted
- 1974-05-07 DD DD178336A patent/DD113919A5/en unknown
- 1974-05-07 IL IL44779A patent/IL44779A/en unknown
-
1980
- 1980-08-07 HK HK412/80A patent/HK41280A/en unknown
-
1981
- 1981-12-30 MY MY128/81A patent/MY8100128A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS623128B2 (en) | 1987-01-23 |
| PL97318B1 (en) | 1978-02-28 |
| IL44779A (en) | 1977-10-31 |
| MY8100128A (en) | 1981-12-31 |
| JPS5069221A (en) | 1975-06-10 |
| GB1473601A (en) | 1977-05-18 |
| NZ174192A (en) | 1985-02-28 |
| DD113919A5 (en) | 1975-07-05 |
| FR2228477A1 (en) | 1974-12-06 |
| AU6869574A (en) | 1975-11-13 |
| SE7406096L (en) | 1975-01-31 |
| IL44779A0 (en) | 1974-07-31 |
| IE42002B1 (en) | 1980-05-21 |
| HK41280A (en) | 1980-08-15 |
| CH622426A5 (en) | 1981-04-15 |
| DE2421943C2 (en) | 1989-10-26 |
| NL7406098A (en) | 1974-11-11 |
| AU524925B2 (en) | 1982-10-14 |
| FR2228477B1 (en) | 1977-07-01 |
| DE2421943A1 (en) | 1974-11-28 |
| CA1057742A (en) | 1979-07-03 |
| AT356263B (en) | 1980-04-25 |
| ATA377074A (en) | 1979-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schally et al. | FSH-releasing hormone and LH-releasing hormone | |
| Wehrenberg et al. | Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats | |
| Borgeat et al. | Inhibition of adenosine 3′, 5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone | |
| IE42002L (en) | Antigens-modified polypeptides | |
| Vilchez-Martinez et al. | Synthesis and biological properties of [Leu-6]-LH-RH and [D-Leu-6, desGly-NH210]-LH-RH ethylamide | |
| KR850007559A (en) | Implantable Formulations of Regulatory Peptides | |
| KR910016340A (en) | Formulations containing stabilized gonadotropin | |
| LU90806I2 (en) | Ovidrelle-choriogonadotropin alfa and its pharmaceutically acceptable derivatives | |
| GB1460522A (en) | Process for the manufacture of antige-coated or antigen-coated or antigen-protein conjugate-coated erythrocytes | |
| HUP0100681A1 (en) | Disulfide cross-linked glycoprotein hormone analogs, their preparation and use | |
| GOSS et al. | Immunologic differentiation of luteinizing hormone and human chorionic gonadotropin in compounds of high purity | |
| Taya et al. | Changes in FSH, LH and prolactin secretion during estrous cycle in rats | |
| Moudgal et al. | Gonadotropins and their antibodies | |
| EP0282343A3 (en) | Method to stimulate the immune response to specific antigens | |
| CA2010256A1 (en) | Protein anti-cancer agent | |
| Fraser et al. | Effect of active immunization to luteinizing hormone releasing hormone on gonadotrophin levels in ovariectomized rats | |
| Arimura et al. | Release of luteinizing hormone by synthetic LH-releasing hormone in the ewe and ram | |
| Solano et al. | Regulation of ovarian gonadotropin receptors and LH bioactivity during the estrous cycle | |
| Li | Preparation of Pepsin Digests of Follicle-Stimulating Hormone (fsh) Possessing Follicle-Stimulating Activity | |
| JPS54126723A (en) | Preparation of specific hcg and specific anti-hcg-beta-subunit antibody | |
| Dupont et al. | Conversion of big pancreatic somatostatin without peptide bond cleavage into somatostatin tetradecapeptide | |
| Eddy et al. | Amphibian metamorphosis: the role of thyrotropin-like hormone | |
| Dörner et al. | The follicle-stimulating and interstitial cell-stimulating activities of pregnant mare serum gonadotrophin compared with those of other gonadotrophins | |
| WO2001024765A3 (en) | Antigenic modification of polypeptides | |
| JPS5411682A (en) | Semiconductor device |